Journal of Affective Disorders
Volume 85, Issue 3 , Pages 259-266 , April 2005

Divalproex in the treatment of bipolar depression: a placebo-controlled study

  • Lori L. Davis

      Affiliations

    • Veteran's Affairs Medical Center (151), 3701 Loop Road East, Tuscaloosa, AL 35404, USA
    • University of Alabama, Birmingham, AL, USA
    • Corresponding Author InformationCorresponding author. Veteran's Affairs Medical Center (151), 3701 Loop Road East, Tuscaloosa, AL 35404, USA. Tel.: +1 205 554 2000; fax: +1 205 554 2877.
    • ,
  • Al Bartolucci

      Affiliations

    • University of Alabama, Birmingham, AL, USA
    • ,
  • Frederick Petty

      Affiliations

    • Omaha Veterans Affairs Medical Center, Omaha, NE
    • Creighton University, Omaha, NE

Received 3 July 2003 ,Accepted 24 September 2004.

References 

  1. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J. Affect. Disord. 2000;59:S5–S30
  2. Bauer M, Zaninelli R, Muller-Orlinghausen B, Meister W. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double blind study. J. Clin. Psychopharmacol. 1999;19(2):164–171
  3. Bauer MS, Callahan AM, Jampala C, Petty F, Sajatovic M, Schaefer V, et al. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J. Clin. Psychiatry. 1999;60:9–21
  4. Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: a naturalistic study. J. Clin. Psychiatry. 1998;59:374–379
  5. Bottlender R, Rudolf D, Strauss A, Moller HJ. Antidepressant-associate maniform states in acute treatment of patients with bipolar I depression. Eur. Arch. Psychiatry Clin. Neurosci. 1998;248:296–300
  6. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak P, Petty F, et al. Efficacy of divalproex sodium vs. lithium and placebo in the treatment of mania. JAMA. 1994;271:918–924
  7. Bowden C, Calabrese JR, Asher J. Spectrum of efficacy of lamotrigine in bipolar disorder: overview of double-blind placebo controlled studies. In: Presented at the 39th annual meeting of the American College of Neuropsychopharmacology; Dec 10–14, 2000a. 2000;San Juan, Puerto Rico
  8. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch. Gen. Psychiatry. 2000;57:481–489
  9. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch. Gen. Psychiatry. 2003;60:392–400
  10. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst. Rev. 2001;2:CD003013
  11. Calabrese JR, Bowden CL, Sachs GS, Aschler JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 study group. J. Clin. Psychiatry. 1999;60:79–88
  12. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J. Clin. Psychiatry. 2003;64:1013–1024
  13. Davis LL, Kabel D, Patel D, Choate AD, Foslien-Nash C, Gurguis G, et al. Valproic acid as an antidepressant in major depressive disorder. Psychopharmacol. Bull. 1996;32:647–652
  14. Davis LL, Ryan W, Adinoff B, Petty F. A comprehensive review of the psychiatric uses of valproate. J. Clin. Psychopharmacol. 2000;20:1S–17S
  15. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J. Clin. Psychopharmacol. 2000;20:607–614
  16. Gibbons RD, Hedeker D, Elkin I. Some conceptual issues in the analysis of longitudinal psychiatric data. Arch. Gen. Psychiatry. 1993;50:739–750
  17. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959;32:50–55
  18. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  19. Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychol. Methods. 1997;2:64–78
  20. Hirschfeld R, Calabrese JR, Weissman M, Frye M, Keck P, McElroy S, et al. Prevalence of bipolar spectrum in US adults [abstract]. Eur. Neuropsychopharmacol. 2002;12:S218
  21. Hirschfeld RMA, Bowden CL, Gitlin MJ, Keck PE, Perlis RH, Suppes T, et al. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry. 2002;159:1–50
  22. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. J. Am. Stat. Assoc. 1995;90:1112–1121
  23. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J. Am. Acad. Child Adolesc. Psych. 1995;34:454–463
  24. Lum M, Fontaine R, Elie R, Ontiveros A. Divalproex sodium's antipanic effect in panic disorder: a placebo-controlled study. Biol. Psychiatry. 1990;27:164A–165A
  25. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch. Gen. Psychiatry. 2002;59:530–537
  26. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch.Gen. Psychiatry. 2003;60:261–269
  27. McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am. J. Psychiatry. 2002;158:420–426
  28. Mendels J. Lithium in the treatment of depression. Am. J. Psychiatry. 1976;133:373–378
  29. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, et al. Double blind, placebo controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am. J. Psychiatry. 2001;158:906–912
  30. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry. 1994;164:549–550
  31. Petty F, Davis L, Nugent AL, Kramer GL, Teten A, Schmitt A, et al. Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J. Clin. Psychopharmacol. 2002;22:100–101
  32. Post RM, Speer AM, Obrocea GV, Leverich GS. Acute and prophylactic effects of anticonvulsants in dipolar depression. Clin. Neurosci. Res. 2002;2:228–251
  33. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The expert consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad. Med. 2000;1–104
  34. Sachs GS, Collins MA, Altshuler LL, Ketter TA, Suppes T, Rasgon NL, et al. Divalproex sodium versus placebo for the treatment of bipolar depression. In: Presented at the 40th annual meeting of the American College of Neuropsychopharacology, December 8, 2001. 2001;San Juan, Puerto Rico
  35. Suppes T, Swann AC, Dennehy EB, Habermacher ED, Mason M, Crismon ML, et al. Texas medication algorithm project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. J. Clin. Psychiatry. 2001;62:439–447
  36. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. Depression during mania: treatment response to lithium or divalproex. Arch. Gen. Psychiatry. 1997;54:37–42
  37. Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine–fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry. 2003;60:1079–1088
  38. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293–299

PII: S0165-0327(04)00371-4

doi: 10.1016/j.jad.2004.09.009

Journal of Affective Disorders
Volume 85, Issue 3 , Pages 259-266 , April 2005

Article Tools

* Image Usage & Resolution